RE:TauRxThanks for keeping us updated on Dundee largest position.
I nominate Catscratch for Chairman of the Board!
Following link is TauRx impact comparison between Genting and Dundee (https://stockhouse.com/companies/bullboard?symbol=t.dc.a&postid=35930083)
The fact that ALL the updates come from Genting is quite sad as a UK listing has a far greater impact on Dundee.
Remember $15B USD is a very old and out of date number.
As I have been saying for a while TauRx is going to be much bigger assuming TauRx gets approved everywhere.
Over time this will likely be the highest revenue drug over the next decade.
1) inexpensive PILL (when compared to total costs of non pills)
2) disease modifying therapy (cholinesterase inhibitors aren't)
3) it works for some people
4) mood enhancer (IMO this is the secret sauce that takes Tau from blockbuster to top selling med over next decade.)